Norda ASA Share Price

Equities

NORD

NO0010285190

Biotechnology & Medical Research

End-of-day quote Norwegian OTC 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
41 NOK 0.00% Intraday chart for Norda ASA 0.00% 0.00%

Financials

Sales 2021 139M 12.66M 1.06B Sales 2022 128M 11.63M 970M Capitalization 204M 18.51M 1.54B
Net income 2021 82M 7.45M 621M Net income 2022 100M 9.08M 758M EV / Sales 2021 0.22 x
Net cash position 2021 159M 14.42M 1.2B Net cash position 2022 257M 23.33M 1.95B EV / Sales 2022 -0.41 x
P/E ratio 2021 *
-
P/E ratio 2022
-
Employees 1
Yield 2021 *
-
Yield 2022
-
Free-Float 6.26%
More Fundamentals * Assessed data
Dynamic Chart
1 week
41.00
Extreme 41
41.00
1 month
41.00
Extreme 41
41.00
Current year
41.00
Extreme 41
41.00
1 year
41.00
Extreme 41
41.00
3 years
38.00
Extreme 38
41.00
5 years
18.00
Extreme 18
41.00
10 years
6.50
Extreme 6.5
41.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 08/13/08
Members of the board TitleAgeSince
Director/Board Member 66 20/13/20
Chairman 52 21/12/21
Director/Board Member - -
More insiders
Date Price Change Volume

End-of-day quote Norwegian OTC, April 26, 2024

More quotes
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
More about the company